Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | GGT1 | P19440 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124171 | 0.87 | LMNA (0.52) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| SCHEMBL6445938 | 0.86 | HPGD (0.49) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| SCHEMBL1428878 | 0.84 | LMNA (0.49) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| SCHEMBL277654 | 0.83 | HPGD (0.56) | KDM4EHSD17B10HPGDALDH1A1LMNA | |
| SCHEMBL30682789 | 0.83 | LMNA (0.55) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| Methoxymethane SCHEMBL5593577 | 0.82 | HPGD (0.55) | KDM4EHSD17B10HPGDALDH1A1LMNA | |
| SCHEMBL20473936 | 0.81 | LMNA (0.46) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| SCHEMBL2818437 | 0.81 | IRAK4 (0.58) | KDM4EHSD17B10HPGDALDH1A1TDP1 | |
| SCHEMBL6442916 | 0.80 | KDM4E (0.47) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 | |
| SCHEMBL9463272 | 0.80 | KDM4E (0.66) | KDM4EHSD17B10HPGDPTGS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108676063-A | A kind of double acyloxy bisamide class pharmaceutical intermediates of hydroxyl and preparation method thereof | 三峡大学 | 2018-10-19 | — | — | CN | claimed |
| CN-106363235-B | A kind of construction field ground material automatic double synchronous cutting equipment and its working method based on PLC controls | 徐州工程学院 | 2018-08-14 | — | — | CN | claimed |
| CN-107722014-A | Salt as hepatitis C virus inhibitors | 广东东阳光药业有限公司 | 2018-02-23 | — | — | CN | claimed |
| CN-103228609-B | Method for producing acyloxybenzoic acids | WEIR CHEMICAL SWITZERLAND LTD | 2015-01-07 | — | — | CN | claimed |
| US-5039717-A | Injection molding cookwear | AMOCO CORPORATION (US) | 1991-08-13 | — | — | US | claimed |
| WO-2025072686-A1 | KRAS G12D MUTATION TARGETING COMPOUNDS | SUMMIT THERAPEUTICS INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025059556-A1 | COMPOSITIONS COMPRISING PRALATREXATE FOR SUBCUTANEOUS ADMINISTRATION AND METHODS OF USE THEREOF | Acrotech Biopharma Inc. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4333903-A1 | COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES | North Carolina State University (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117500494-A | Advantageous anti-HCV combination therapies | 阿堤亚制药公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023281272-A1 | NASAL SPRAY | Pollinner Limited (GB) | 2023-01-12 | — | — | WO | disclosed |
| WO-2023278827-A1 | 3-IODOPROPYL-1,2,3-TRIAZOL-1-YL, 3-BROMOPROPYL-1,2,3-TRIAZOL-1-YL, AND DERIVATIVES FOR USES IN LABELING | EMORY UNIVERSITY (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022235566-A1 | COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES | NORTH CAROLINA STATE UNIVERSITY (US) | 2022-11-10 | — | — | WO | disclosed |
| EP-0329904-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329905-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329903-A1 | Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329932-A2 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments | MERRELL PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0284256-A1 | Benzodiazepine analogs | MERCK & CO. INC. (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0099080-B1 | SUBSTITUTED TETRAHYDROTETRAZOLO(5,1-A)PHTHALAZINES | THE DOW CHEMICAL COMPANY (US) | 1988-02-03 | — | — | EP | disclosed |
| CN-85109752-A | Preparation triterpenoid organic acid ester and the method that contains the hypolipidemic agents of this compounds | — | 1986-12-17 | — | — | CN | disclosed |
| US-4021565-A | Process for the alleviation of depression by administration of non-addicting meperidine analogues | BERGER FRANK M | 1977-05-03 | — | — | US | disclosed |